Viridian Therapeutics Inc. (0K1R:LSE) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Viridian Therapeutics Inc. stock forecast from 0 analysts, the average analyst target price for Viridian Therapeutics Inc. is not available over the next 12 months. Viridian Therapeutics Inc.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Viridian Therapeutics Inc. is Very Bearish, which is based on 0 positive signals and 1 negative signals. At the last closing, Viridian Therapeutics Inc.’s stock price was USD 14.18. Viridian Therapeutics Inc.’s stock price has changed by +12.76% over the past week, -14.73% over the past month and -49.01% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for 0K1R:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
